Skip to main content English

Detail

Daniel Steiner
Dr. Daniel Steiner

Department of Medicine I (Division of Hematology and Hemostaseology)
Position: Doctor-in-training

ORCID: 0000-0002-4170-603X
T +43 1 40400 44170
daniel.steiner@meduniwien.ac.at

Keywords

Epidemiology; Hematologic Neoplasms; Hemorrhage; Patient-Centered Care; Quality of Life; Venous Thromboembolism; Vulnerable Populations

Research group(s)

  • Thrombosis and Haemostasis Research Group
    Head: Cihan Ay
    Research Area: Our research focuses on thrombosis and haemostasis, with a particular interest in improving the understanding of risk, clinical course and mechanisms of venous thrombosis and bleeding disorders such as haemophilia. The Thrombosis & Haemostasis Research Group is part of the Department of Medicine I, Clinical Division of Haemotology and Haemostaseology, and jointly affiliated with Comprehensive Cancer Center, Cardiovascular Cluster and the Comprehensive Center for Cardiovascular Medicine.
    Members:

Selected publications

  1. Steiner, D. et al. (2024) ‘Anxiety in patients with venous thromboembolism: quantification and risk factors in a prospective cohort study’, Journal of Thrombosis and Haemostasis, 22(12), pp. 3490–3499. Available at: https://doi.org/10.1016/j.jtha.2024.07.016.
  2. Steiner, D. et al. (2025) ‘Hemostatic and inflammatory biomarkers are associated with functional limitations after venous thromboembolism: A prospective cohort study’, Seminars in Thrombosis and Hemostasis [Preprint]. Available at: https://doi.org/10.1055/a-2574-8775.
  3. Steiner, D. et al. (2023) ‘The post-VTE functional status scale for assessment of functional limitations in patients with venous thromboembolism: Construct validity and responsiveness in a prospective cohort study’, Thrombosis Research, 221, pp. 1–6. Available at: https://doi.org/10.1016/j.thromres.2022.11.006.
  4. Steiner, D. et al. (2023) ‘Risk of Depression after Venous Thromboembolism in Patients with Hematological Cancer: A Population-Based Cohort Study’, Thrombosis and Haemostasis, 125(03), pp. 255–264. Available at: https://doi.org/10.1055/a-2225-5428.
  5. Steiner, D. et al. (2025) ‘A Systematic Review of Safety and Efficacy of Factor XI/XIa Inhibitors in Patients With ESKD on Hemodialysis’, Kidney International Reports, 10(1), pp. 145–156. Available at: https://doi.org/10.1016/j.ekir.2024.10.007.